Development of a highly effective combination monoclonal antibody therapy against Herpes simplex virus.

Narges SeyfizadehDavid KalbermatterThomas ImhofMoritz RiesChristian MüllerLeonie JennerElisabeth BlumenscheinAlexandra YendrzheyevskiyFrank GrünKevin MoogDaniel EckertRonja EngelPhilipp DiebolderMohamed ChamiJürgen KraussTorsten SchallerMichaela Arndt

Published in: Journal of biomedical science (2024)

This biochemical and immunological study showcases the potential of an effective combination therapy with two monoclonal anti-gB IgGs for the treatment of HSV-1/2 induced disease conditions.

Keyphrases

combination therapy
herpes simplex virus
monoclonal antibody
high glucose
diabetic rats
stem cells
oxidative stress
multiple myeloma
human health
mesenchymal stem cells
climate change
replacement therapy